Orchiectomy reduces hepatotumorigenesis of H-ras12V transgenic mice via the MAPK pathway

Life Sciences

Volumn 79, Issue 21, 2006, Pages 1974-1980

  Wang, Ai Guo ^a   Moon, Hyung Bae ^b   Chun, Sang Young ^c   Lee, Tae Hoon ^c   Yu, Dae Yeul ^a   Lee, Dong Seok ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Wonkwang University   (South Korea)

^c Chonnam National University   (South Korea)

Author keywords

Hepatotumorigenesis; Orchiectomy; Ovariectomy; Sex hormones; Transgenic mice

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; SEX HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; INCIDENCE; LIVER CARCINOGENESIS; MALE; MOLECULAR GENETICS; MOUSE; NONHUMAN; ONCOGENE H RAS; ORCHIECTOMY; OVARIECTOMY; SEX HORMONE DETERMINATION; SIGNAL TRANSDUCTION; TESTIS; TRANSGENIC MOUSE; TREATMENT OUTCOME;

ANIMALS; FEMALE; GENES, RAS; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; ORCHIECTOMY; OVARIECTOMY; RAS PROTEINS; SEX FACTORS; SIGNAL TRANSDUCTION; TESTOSTERONE; TRANSGENES;

ANIMALIA; MUS MUSCULUS;

EID: 33749613807     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.06.032     Document Type: Article

References (34)

1. Tamoxifen in treatment of hepatocellular carcinoma: a randomised controlled trial. CLIP Group (Cancer of the Liver Italian Programme). Lancet 352 9121 (1998) 17-20
2. Batchelor J.R., and Chapman B.A. The influence of sex upon the antibody response to an incompatible tumour. Immunology 9 6 (1965) 553-564
3. Bos J.L. ras oncogenes in human cancer: a review. Cancer Research 49 17 (1989) 4682-4689
4. Chao Y., Chan W.K., Huang Y.S., Teng H.C., Wang S.S., Lui W.Y., Whang-Peng J., and Lee S.D. Phase II study of flutamide in the treatment of hepatocellular carcinoma. Cancer 77 4 (1996) 635-639
5. De Maria N., Manno M., and Villa E. Sex hormones and liver cancer. Molecular and Cellular Endocrinology 193 1-2 (2002) 59-63
6. Deane N.G., Parker M.A., Aramandla R., Diehl L., Lee W.J., Washington M.K., Nanney L.B., Shyr Y., and Beauchamp R.D. Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice. Cancer Research 61 14 (2001) 5389-5395
7. Eagon P.K., Porter L.E., Francavilla A., DiLeo A., and Van Thiel D.H. Estrogen and androgen receptors in liver: their role in liver disease and regeneration. Seminars in Liver Disease 5 1 (1985) 59-69
8. Fausto N., and Webber E.M. Control of liver growth. Critical Reviews in Eukaryotic Gene Expression 3 2 (1993) 117-135
9. Firminger H.I., and Reuber M.D. Influence of adrenocortical, androgenic, and anabolic hormones on the development of carcinoma and cirrhosis of the liver in A x C rats fed N-2-fluorenyldicetamide. Journal of the National Cancer Institute 27 (1961) 559-595
10. Graziani A., Gramaglia D., dalla Zonca P., and Comoglio P.M. Hepatocyte growth factor/scatter factor stimulates the Ras-guanine nucleotide exchanger. Journal of Biological Chemistry 268 13 (1993) 9165-9168
11. Grimaldi C., Bleiberg H., Gay F., Messner M., Rougier P., Kok T.C., Cirera L., Cervantes A., De Greve J., Paillot B., Buset M., Nitti D., Sahmoud T., Duez N., and Wils J. Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial. Journal of Clinical Oncology 16 2 (1998) 411-417
12. Huynh H.T., Nguyen T.T., Chow P.K., Tan P.H., Soo K.C., and Tran E. Overexpression of MEK-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. BMC Gastroenterology 3 1 (2003) 19
13. Johnson P.J. Sex hormones and the liver. Clinical Science (Lond) 66 4 (1984) 369-376
14. Kemp C.J., Leary C.N., and Drinkwater N.R. Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous. Proceedings of the National Academy of Sciences of the United States of America 86 19 (1989) 7505-7509
15. Kiba T., Tsuda H., Pairojkul C., Inoue S., Sugimura T., and Hirohashi S. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand. Molecular Carcinogenesis 8 4 (1993) 312-318
16. Kim C.M., Koike K., Saito I., Miyamura T., and Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351 6324 (1991) 317-320
17. Liu C.L., Fan S.T., Ng I.O., Lo C.M., Poon R.T., and Wong J. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study. American Journal of Gastroenterology 95 1 (2000) 218-222
18. Migliaccio A., Castoria G., Di Domenico M., de Falco A., Bilancio A., Lombardi M., Bottero D., Varricchio L., Nanayakkara M., Rotondi A., and Auricchio F. Sex steroid hormones act as growth factors. Journal of Steroid Biochemistry and Molecular Biology 83 1-5 (2002) 31-35
19. Moriya K., Fujie H., Shintani Y., Yotsuyanagi H., Tsutsumi T., Ishibashi K., Matsuura Y., Kimura S., Miyamura T., and Koike K. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Natural Medicine 4 9 (1998) 1065-1067
20. Nagasue N., Ito A., Yukaya H., and Ogawa Y. Androgen receptors in hepatocellular carcinoma and surrounding parenchyma. Gastroenterology 89 3 (1985) 643-647
21. Pethe V., and Shekhar P.V. Estrogen inducibility of c-Ha-ras transcription in breast cancer cells. Identification of functional estrogen-responsive transcriptional regulatory elements in exon 1/intron 1 of the c-Ha-ras gene. Journal of Biological Chemistry 274 43 (1999) 30969-30978
22. Porter L.E., Elm M.S., Van Thiel D.H., Dugas M.C., and Eagon P.K. Characterization and quantitation of human hepatic estrogen receptor. Gastroenterology 84 4 (1983) 704-712
23. Reynolds S.H., Stowers S.J., Maronpot R.R., Anderson M.W., and Aaronson S.A. Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse. Proceedings of the National Academy of Sciences of the United States of America 83 1 (1986) 33-37
24. Reynolds S.H., Stowers S.J., Patterson R.M., Maronpot R.R., Aaronson S.A., and Anderson M.W. Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. Science 237 4820 (1987) 1309-1316
25. Rossini G.P., Baldini G.M., Villa E., and Manenti F. Characterization of estrogen receptor from human liver. Gastroenterology 96 4 (1989) 1102-1109
26. Roy A.K., Milin B.S., and McMinn D.M. Androgen receptor in rat liver: hormonal and developmental regulation of the cytoplasmic receptor and its correlation with the androgen-dependent synthesis of alpha2u-globulin. Biochimica et Biophysica Acta 354 2 (1974) 213-232
27. Saitoh A., Kimura M., Takahashi R., Yokoyama M., Nomura T., Izawa M., Sekiya T., Nishimura S., and Katsuki M. Most tumors in transgenic mice with human c-Ha-ras gene contained somatically activated transgenes. Oncogene 5 8 (1990) 1195-2000
28. Sato N., Ota M., and Obara K. Presence of binding component(s) for testosterone in rat liver cytosol. Endocrinologia Japonica 27 3 (1980) 315-319
29. Simpson E.R., and Davis S.R. Minireview: aromatase and the regulation of estrogen biosynthesis-some new perspectives. Endocrinology 142 11 (2001) 4589-4594
30. Simpson E.R. Sources of estrogen and their importance. Journal of Steroid Biochemistry and Molecular Biology 86 3-5 (2003) 225-230
31. Staib F., Hussain S.P., Hofseth L.J., Wang X.W., and Harris C.C. TP53 and liver carcinogenesis. Human Mutation 21 3 (2003) 201-216
32. Strom S.C., and Faust J.B. Oncogene activation and hepatocarcinogenesis. Pathobiology 58 3 (1990) 153-167
33. Tanaka K., Sakai H., Hashizume M., and Hirohata T. Serum testosterone:estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients. Cancer Research 60 18 (2000) 5106-5110
34. Wang A.G., Moon H.B., Lee M.R., Hwang C.Y., Kwon K.S., Yu S.L., Kim Y.S., Kim M., Kim J.M., Kim S.K., Lee T.H., Moon E.Y., Lee D.S., and Yu D.Y. Gender-dependent hepatic alterations in H-ras12V transgenic mice. Journal of Hepatology 43 5 (2005) 836-844